Focused on the critical role of digitalization, statistical analysis, and GxP compliance in pharmaceutical manufacturing. These articles highlight how Novatek International’s validated digital solutions help pharmaceutical manufacturers improve data integrity, regulatory compliance, and operational efficiency. Regulatory-readiness (21 CFR Part 11) for laboratory management auditing, drives Novatek International to prioritize drug stability through accurate shelf life predictions, automated trending and statistical analysis, and reporting.